Haematologica
HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Papadopoulos, V
Right arrow Articles by Loukopoulos, D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Papadopoulos, V
Right arrow Articles by Loukopoulos, D
Haematologica, Vol 90, Issue 2, 255-257
Copyright © 2005 by Ferrata Storti Foundation

Letter

HbO-Arab mutation originated in the Pomak population of Greek Thrace

V Papadopoulos, E Dermitzakis, D Konstantinidou, D Petridis, G Xanthopoulidis, and D Loukopoulos

HbO-Arab emerged about 2,000 years on a rare haplotype, characteristic of the Greek Pomaks. Its frequency increased as a consequence of high genetic drift within this population, and it was dispersed throughout the Mediterranean basin and Middle East with minor variations of its haplotypic pattern.


This article has been cited by other articles:


Home page
 BloodHome page
A. A. Chanan-Khan, J. L. Kaufman, J. Mehta, P. G. Richardson, K. C. Miller, S. Lonial, N. C. Munshi, R. Schlossman, J. Tariman, and S. Singhal
Activity and safety of bortezomib in multiple myeloma patients with advanced renal failure: a multicenter retrospective study
Blood, March 15, 2007; 109(6): 2604 - 2606.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
Copyright © 2005 by the Ferrata Storti Foundation.